Non-invasive visualization of the lipid product of class I PI3K in transgenic mouse models.

Non-invasive visualization of the lipid product of class I PI3K in transgenic mouse models.
复制标题

DOI:
10.1042/bst0350215
复制
发表时间:
2007-04
影响因子:
3.9
通讯作者:
T. Sasaki;J. Sasaki;K. Watanabe;A. Suzuki
T. Sasaki;J. Sasaki;K. Watanabe;A. Suzuki
中科院分区:
生物学3区
文献类型:
--
作者:
T. Sasaki;J. Sasaki;K. Watanabe;A. Suzuki

文献摘要

被引文献

相似文献

磷脂酰肌醇3激酶(phosphoinositide 3-kinases,PI 3 Ks)通过产生3,4,5-三磷酸磷脂酰肌醇(phosphatidylinositol 3,4,5-trisphosphate,PI(3,4,5)P(3))调节许多重要的细胞反应。为了促进PI(3,4,5)P(3)在活的原代细胞中的时空表征,我们产生了表达PI(3,4,5)P(3)/PI(3,4)P(2)(磷脂酰肌醇3,4-二磷酸)的荧光生物探针的转基因小鼠[AktPH(Akt pleckstrin同源结构域)-GFP(绿色荧光蛋白)Tg(转基因)小鼠]的新品系。通过将AktPH-GFP Tg小鼠与缺乏特定磷酸肌醇代谢酶的基因靶向“敲除”小鼠品系杂交,我们已经能够评估每种酶对PI(3,4,5)P(3)在迁移中性粒细胞中定位的贡献。我们的研究结果表明,在fMet-Leu-Phe(N-甲酰甲硫氨酰-亮氨酰苯丙氨酸;“趋化肽”)刺激的中性粒细胞迁移过程中,PI 3 K γ和PI(3,4,5)P(3)磷酸酶SHIP 1 [含SH 2(Src同源2)的肌醇磷酸酶-1]是PI(3,4,5)P(3)动力学的关键调节因子。我们的研究也验证了荧光转基因策略在生理和病理情况下研究PI(3,4,5)P(3)代谢。
PI3Ks (phosphoinositide 3-kinases) regulate many critical cellular responses by producing PI(3,4,5)P(3) (phosphatidylinositol 3,4,5-trisphosphate). To facilitate the spatio-temporal characterization of PI(3,4,5)P(3) in living primary cells, we generated a novel strain of transgenic mice [AktPH (Akt pleckstrin homology domain)-GFP (green fluorescent protein) Tg (transgenic) mice] that express a fluorescent bioprobe for PI(3,4,5)P(3)/PI(3,4)P(2) (phosphatidylinositol 3,4-bisphosphate). By crossing AktPH-GFP Tg mice with strains of gene-targeted 'knockout' mice lacking a particular phosphoinositide-metabolizing enzyme, we have been able to evaluate the contribution of each enzyme to PI(3,4,5)P(3) localization in migrating neutrophils. Our results indicate that PI3Kgamma and the PI(3,4,5)P(3) phosphatase SHIP1 [SH2 (Src homology 2)-containing inositol phosphatase-1] are the key regulators of PI(3,4,5)P(3) dynamics during fMet-Leu-Phe (N-formylmethionyl-leucylphenylalanine; 'chemotactic peptide')-stimulated neutrophil migration. Our study has also validated the fluorescent transgenic strategy for studying PI(3,4,5)P(3) metabolism in physiological and pathological situations.